Six international consortia searching for cancer cures have won a total of £30 million under a scheme jointly funded by Cancer Research UK and two European charities.
The five-year projects will be funded under the Accelerator Award scheme, a translational initiative managed by CRUK, Italy’s AIRC (Associazione Italiana per la Ricerca sul Cancro) and Spain’s AECC (Asociación Española Contra el Cáncer).
The winners of the call, announced on 18 September, will investigate the potential of immunotherapies in treating liver cancer; develop methods to manufacture immune cells that attack tumours; track cancer cell evolution; investigate drug resistance in blood cancers; devise a blood test for advanced prostate cancer, and find new ways of personalising blood cancer treatment. Some of the projects will also be focused on training junior scientists and clinicians.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.